Latest Videos |view all videos
David Dingli, M.D., Ph.D., a professor of medicine and member of the Division of Hematology at Mayo Clinic in Rochester, Minnesota, updates clinicians and patients on new treatment options for this increasingly complicated disease progression.
This Breast Health Center Grand Rounds introduces the evidence of acupuncture's effectiveness in managing key symptoms of cancer treatment.
Mayo Clinic physicians John B. Kisiel, M.D., and David W. Larson, M.D., M.B.A., discuss the latest advancements in colorectal cancer screening, as well as the latest surgical techniques available for people with colorectal cancer.
Mayo Clinic's multidisciplinary team of experts discuss hematologic malignancies and the latest developments in the treatment of these cancers.
Medical oncologists, Scott H. Okuno, M.D., Steven I. Robinson, M.B.B.S., and orthopedic surgeon, Peter S. Rose, M.D., discuss sarcomas — a group of rare soft tissue and bone cancers — and the unique treatment options for these cancers.
Mayo Clinic specialists describe considerations and advancements in surgical techniques used in the treatment of testicular cancer, bladder cancer and kidney cancer.
Mayo Clinic experts in Arizona discuss the new facility, which allows them to create a seamless experience for patients by integrating all cancer services from prevention to survivorship.
Mayo Clinic's multidisciplinary team of experts discusses developments in diagnostic tools, imaging, neurosurgery, and radiation therapy that allow them to create personalized care plans for people with brain and central nervous system cancers.
Mayo Clinic physicians and researchers discuss how the molecular makeup of brain tumors can be used to identify five categories of gliomas, each with different clinical features and outcomes.
In their bid to find the best combination of therapies to treat anaplastic thyroid cancer, John A. Copland III, Ph.D., and a team of researchers at Mayo Clinic's campus in Florida demonstrated that all histone deacetylase (HDAC) inhibitors ...
The genetic makeup of colon cancer tumors and survival rates for people with the disease differ by race, according to a study from researchers at the Mayo Clinic Cancer Center.
Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use, according to a study by Mayo Clinic researchers published in the current issue of the journal BMC Cancer.